Insulin-producing β-islet cells in the pancreas can be made aware of a lack of insulin in the blood in a diabetes model, through signals relayed by a soluble signaling molecule called T-cadherin, report scientists at the University of Osaka in Japan. The novel mechanism, reported in the journal iScience on November 7, presents a potential new therapeutic target for treating diabetes.
